Sigachi Industries Limited (SIGACHI.BO)
INR 52.77
(2.73%)
INR 52.77
(2.73%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.43 Billion INR | 108.9% |
| 2022 | 684.78 Million INR | 96.19% |
| 2021 | 349.03 Million INR | 66.79% |
| 2020 | 209.26 Million INR | -31.11% |
| 2019 | 303.79 Million INR | 20.6% |
| 2018 | 251.91 Million INR | -17.16% |
| 2017 | 304.09 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 959.72 Million INR | 0.0% |
| 2023 FY | 1.43 Billion INR | 108.9% |
| 2023 Q4 | 1.43 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 FY | 684.78 Million INR | 96.19% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 660.26 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 684.78 Million INR | 0.0% |
| 2021 Q1 | 255.91 Million INR | 22.29% |
| 2021 FY | 349.03 Million INR | 66.79% |
| 2021 Q4 | 349.03 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 315.7 Million INR | 23.37% |
| 2020 Q4 | 209.26 Million INR | 0.0% |
| 2020 FY | 209.26 Million INR | -31.11% |
| 2020 Q1 | - INR | 0.0% |
| 2019 FY | 303.79 Million INR | 20.6% |
| 2018 FY | 251.91 Million INR | -17.16% |
| 2017 FY | 304.09 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -305.475% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -8177.018% |
| Bal Pharma Limited | 1.39 Billion INR | -2.437% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -760.637% |
| Medico Remedies Limited | 80.5 Million INR | -1676.951% |
| Lasa Supergenerics Limited | 220.76 Million INR | -547.991% |
| Venus Remedies Limited | 413.3 Million INR | -246.121% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -133.936% |
| Alpa Laboratories Limited | 52.46 Million INR | -2626.612% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 77.491% |
| Shilpa Medicare Limited | 9.37 Billion INR | 84.739% |
| Aarti Drugs Limited | 5.64 Billion INR | 74.648% |
| Lupin Limited | 29.21 Billion INR | 95.104% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 97.848% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 82.212% |
| Windlas Biotech Limited | 36.41 Million INR | -3828.912% |
| Suven Life Sciences Limited | 7.09 Million INR | -20056.644% |
| Eris Lifesciences Limited | 27.81 Billion INR | 94.857% |
| Valiant Laboratories Limited | 767.08 Million INR | -86.488% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 62.122% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 85.857% |
| Ipca Laboratories Limited | 14.38 Billion INR | 90.055% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -43.281% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 95.63% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 57.019% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 30.95% |
| Laurus Labs Limited | 25.77 Billion INR | 94.45% |
| Piramal Pharma Limited | 47.1 Billion INR | 96.963% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -97.349% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 96.443% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 72.123% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 88.379% |
| Unichem Laboratories Limited | 2.47 Billion INR | 42.205% |
| Sequent Scientific Limited | 4.87 Billion INR | 70.668% |
| Novartis India Limited | 69.7 Million INR | -1952.392% |
| Wanbury Limited | 1.16 Billion INR | -22.807% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -120.092% |
| Wockhardt Limited | 23.56 Billion INR | 93.928% |
| Themis Medicare Limited | 957.92 Million INR | -49.335% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -1499.952% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 96.096% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -734.218% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 92.855% |
| Divi's Laboratories Limited | 30 Million INR | -4668.39% |
| NATCO Pharma Limited | 3.71 Billion INR | 61.462% |
| Gufic Biosciences Limited | 3.32 Billion INR | 57.031% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -336.666% |
| Ind-Swift Limited | 10.13 Billion INR | 85.892% |
| Procter & Gamble Health Limited | 95.6 Million INR | -1396.357% |
| FDC Limited | 205.18 Million INR | -597.184% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 26.045% |
| Granules India Limited | 13.15 Billion INR | 89.122% |
| Medicamen Biotech Limited | 308.17 Million INR | -364.194% |
| Alkem Laboratories Limited | 14.18 Billion INR | 89.915% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -3011.037% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -32493.233% |
| Brooks Laboratories Limited | 56.41 Million INR | -2435.523% |
| Megasoft Limited | 1.47 Billion INR | 2.717% |
| ZIM Laboratories Limited | 1.08 Billion INR | -31.452% |
| Strides Pharma Science Limited | 25.16 Billion INR | 94.316% |
| Neuland Laboratories Limited | 953.89 Million INR | -49.966% |
| Morepen Laboratories Limited | 289.99 Million INR | -393.295% |
| Hikal Limited | 8.17 Billion INR | 82.503% |
| Indoco Remedies Limited | 6.71 Billion INR | 78.711% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 49.85% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -352.03% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -45.241% |
| Hester Biosciences Limited | 2.44 Billion INR | 41.463% |